Related Experiment Video
Updated: Aug 30, 2026
Identification of Rare Antigen-Specific T Cells from Mouse Lungs with Peptide:Major Histocompatibility Complex Tetramers
Published on: July 19, 2024
Isolation of lung tumor specific peptides from a random peptide library: generation of diagnostic and cell-targeting
Tsuksa Oyama1, Kathryn F Sykes, Kausar N Samli
1Center for Biomedical Inventions, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390-9185, USA.
Abstract:
Discovery of ligands specific to receptor(s) on a surface of a cancer cell could impact clinical issues including functional diagnosis and cell-specific drug delivery. Using a phage display approach, we have isolated 20-mer peptide ligands that bind to 3 different human lung tumor cell lines, NCI-H1299, NCI-H2009, and A549. The panning protocol is unbiased with no selection pressure towards binding a particular cellular receptor. The isolated phage bind to their target cells 24-300 times better than a control phage. Furthermore, the isolated peptides display remarkable cell-specificities and are able to discriminate between normal and cancerous cells as well as different lung tumor cells. The cell-specificities are not coincident with tumor classes indicating that the peptides are able to recognize cell-surface features that are not represented within the classification of tumor type. The isolated peptides are functional outside of the context of the phage and multimerization of the peptide increases its affinity for its given cell type, thus expanding their utility in clinical situations.
Insights
Researchers discovered peptide ligands that bind specifically to lung cancer cells. These ligands show potential for improved cancer diagnosis and targeted drug delivery, distinguishing between normal and cancerous cells.
Area of Science:
- Oncology
- Biotechnology
- Molecular Biology
Background:
- Targeted cancer therapies require specific ligands for cancer cell surface receptors.
- Identifying such ligands is crucial for advancing cancer diagnosis and drug delivery systems.
Purpose of the Study:
- To isolate and characterize novel peptide ligands that bind specifically to human lung tumor cell lines.
- To evaluate the potential of these ligands for clinical applications in cancer diagnosis and therapy.
Main Methods:
- Phage display technology was employed to screen for peptide ligands against three human lung tumor cell lines (NCI-H1299, NCI-H2009, A549).
- An unbiased panning protocol was used, without selection for specific cellular receptors.
- Binding affinity and specificity of isolated phage-displayed peptides were assessed against target and control cells.
Main Results:
- Twenty-mer peptide ligands were successfully isolated, exhibiting 24-300 fold higher binding to target lung tumor cells compared to control phage.
- The isolated peptides demonstrated significant cell-specificities, differentiating between normal and cancerous cells, and even among different lung tumor cell types.
- Peptide specificity was not correlated with tumor classification, suggesting recognition of unique cell-surface features.
Conclusions:
- The identified peptide ligands are effective in recognizing and binding to specific lung cancer cells.
- These peptides function independently of the phage display system, and their affinity can be enhanced through multimerization.
- The findings support the potential utility of these peptide ligands in clinical settings for cancer diagnosis and targeted drug delivery.
